| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |